Silvestri Romano, De Martino Gabriella, La Regina Giuseppe, Artico Marino, Massa Silvio, Vargiu Laura, Mura Massimo, Loi Anna Giulia, Marceddu Tiziana, La Colla Paolo
Istituto Pasteur - Fondazione Cenci Bolognetti, Dipartimento di Studi Farmaceutici, Università di Roma La Sapienza, Piazzale A. Moro 5, Italy.
J Med Chem. 2003 Jun 5;46(12):2482-93. doi: 10.1021/jm0211063.
The potent anti-HIV-1 activities of L-737,126 (2) and PAS sulfones prompted us to design and test against HIV-1 in acutely infected MT-4 cells a number of novel 1- and 3-benzenesulfonylindoles. Indoles belonging to the 1-benzenesulfonyl series were found poorly or totally inactive. On the contrary, some of the 3-benzenesulfonyl derivatives turned out to be as potent as 2, being endowed with potencies in the low nanomolar concentration range. In particular, (2-methylphenyl)sulfonyl (72) and (3-methylphenyl)sulfonyl (73) derivatives showed EC(50) values of 1 nM. Introduction of two methyl groups at positions 3 and 5 of the phenyl ring of 2 furnished derivatives (80 and 83) which showed very potent and selective anti-HIV-1 activity not only against the wt strain, but also against mutants carrying NNRTI-resistant mutations at positions 103 and 181 of the reverse transcriptase gene.
L-737,126(2)和对氨基苯磺酰砜的强效抗HIV-1活性促使我们设计并在急性感染的MT-4细胞中针对HIV-1测试了许多新型的1-和3-苯磺酰基吲哚。属于1-苯磺酰基系列的吲哚被发现活性很差或完全无活性。相反,一些3-苯磺酰基衍生物的活性与2相当,在低纳摩尔浓度范围内具有效力。特别是,(2-甲基苯基)磺酰基(72)和(3-甲基苯基)磺酰基(73)衍生物的EC50值为1 nM。在2的苯环的3和5位引入两个甲基得到的衍生物(80和83)不仅对野生型毒株,而且对在逆转录酶基因的103和181位携带非核苷类逆转录酶抑制剂抗性突变的突变体都显示出非常强效和选择性的抗HIV-1活性。